The natural anticoagulant protein S; hemostatic functions and deficiency

References

• Schiffman FJ. Hematologic pathophysiology. In: The Clinical Pathophysiology. 5th ed. 1998. p. 75–102.
   Google Scholar
• Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med. 1995;46(1):103–8. doi:10.1146/annurev.med.46.1.103.
   Google Scholar
• Livio M, Vigano G, Morigi M, Ubiali A, Galbusera M, Remuzzi G. Role of platelet-activating factor in primary hemostasis. Am J Physiol Heart Circ Physiol. 1988;254(6):H1218–23. doi:10.1152/ajpheart.1988.254.6.H1218.
   Google Scholar
• Lawkowicz W, Michalowska R, Slomkowski M. Disturbances in hemostasis in secondary thrombocytopenia in the light of studies on platelet aggregation. Pol Arch Med Wewn. 1969;43:1555–62.
   Google Scholar
• Faulk WP, Labarrere CA, Nelson DR, Pitts D. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis. J Heart Lung Transplant. 1995;14:S158–64.
   Web of Science ®Google Scholar
• Yamazaki H, Fujimoto T, Suzuki H, Akamatsu N, Katagiri Y, Yamaguchi A, Tanoue K. Interaction of platelets and blood vessels–vascular injuries induced by platelet activation in vivo. Jpn Circ J. 1992;56(2):178–86. doi:10.1253/jcj.56.178.
   Google Scholar
• Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. 1997;89(9):3213–8. doi:10.1182/blood.V89.9.3213.
   PubMed Web of Science ®Google Scholar
• Mertens K, Bertina RM. Activation of human coagulation factor VIII by activated factor X, the common product of the intrinsic and the extrinsic pathway of blood coagulation. Thromb Haemost. 1982;47(2):96–100. doi:10.1055/s-0038-1657137.
   Web of Science ®Google Scholar
• Tomaiuolo M, Brass LF, Stalker TJ. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis. Interv Cardiol Clin. 2017;6(1):1–12. doi:10.1016/j.iccl.2016.08.001.
   PubMedGoogle Scholar
• Colvin BT. Physiology of haemostasis. Vox Sang. 2004;87(Suppl 1):43–6. doi:10.1111/j.1741-6892.2004.00428.x.
   Google Scholar
• Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis. 2002;13(8):657–70. doi:10.1097/00001721-200212000-00001.
   PubMed Web of Science ®Google Scholar
• Justus AC, Roussev R, Norcross JL, Faulk WP. Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin. Thromb Res. 1995;79(2):175–86. doi:10.1016/0049-3848(95)00103-X.
   Web of Science ®Google Scholar
• Ishida Y, Yano K, Ito T, Shigematus H, Sasaki K, Kondo S, Kuriya S-I. Purification of proplatelet formation (PPF) stimulating factor: thrombin/antithrombin III complex stimulates PPF of megakaryocytes in vitro and platelet production in vivo. Thromb Haemost. 2001;85(2):349–55. doi:10.1055/s-0037-1615691.
   Web of Science ®Google Scholar
• He S, Bremme K, Blomback M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagul Fibrinolysis. 1997;8(4):232–8. doi:10.1097/00001721-199706000-00004.
   Web of Science ®Google Scholar
• Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparan sulfate. Crit Care Med. 2002;30(5 Suppl):S325–31. doi:10.1097/00003246-200205001-00024.
   PubMed Web of Science ®Google Scholar
• Hermann H, Galloni L, Cier JF. Is antithrombin formed by the reticuloendothelial tissue? C R Seances Soc Biol Fil. 1945;139:1134.
   Google Scholar
• Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the subcommittee on tissue factor pathway inhibitor (TFPI) of the scientific and standardization committee of the ISTH. Thromb Haemost. 1995;73(5):873–5. doi:10.1055/s-0038-1653884.
   Google Scholar
• Ellery PER, Hilden I, Sejling K, Loftager M, Martinez ND, Maroney SA, Mast AE. Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and protein S. Res Pract Thromb Haemost. 2018;2(1):93–104. doi:10.1002/rth2.12058.
   Web of Science ®Google Scholar
• Kato H. Tissue factor pathway inhibitor; its structure, function and clinical significance. Pol J Pharmacol. 1996;48:67–72.
   PubMedGoogle Scholar
• van ‘t Veer C, Butenas S, Golden N, Mann K. Regulation of prothrombinase activity by protein S. Thromb Haemost. 1999;82(1):80–7. doi:10.1055/s-0037-1614633.
   Web of Science ®Google Scholar
• Kim PY, Nesheim ME. Down regulation of prothrombinase by activated protein C during prothrombin activation. Thromb Haemost. 2010;104(1):61–70. doi:10.1160/TH09-09-0650.
   Web of Science ®Google Scholar
• Dahlback B. Vitamin K-dependent protein S: beyond the protein C pathway. Semin Thromb Hemost. 2018;44(2):176–84. doi:10.1055/s-0037-1604092.
   Web of Science ®Google Scholar
• Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem. 1980;255(12):5521–4. doi:10.1016/S0021-9258(19)70660-7.
   PubMed Web of Science ®Google Scholar
• Xu J, Esmon NL, Esmon CT. Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem. 1999;274(10):6704–10. doi:10.1074/jbc.274.10.6704.
   Web of Science ®Google Scholar
• Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med. 2001;29(7 Suppl):S48–51; discussion 51–2. doi:10.1097/00003246-200107001-00018.
   Web of Science ®Google Scholar
• Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry. 1977;16(4):698–706. doi:10.1021/bi00623a022.
   Web of Science ®Google Scholar
• Saller F, Villoutreix BO, Amelot A, Kaabache T, Le Bonniec BF, Aiach M, Gandrille S, Borgel D. The γ-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding. Blood. 2005;105(1):122–30. doi:10.1182/blood-2004-06-2176.
   Web of Science ®Google Scholar
• Borgel D, Gaussem P, Garbay C, Bachelot-Loza C, Kaabache T, Liu W-Q, Brohard-Bohn B, Le Bonniec B, Aiach M, Gandrille S. et al. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the γ-carboxyglutamic acid-rich domain. Biochem J. 2001;360(2):499–506. doi:10.1042/bj3600499.
   Google Scholar
• Suleiman L, Negrier C, Boukerche H. Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol. 2013;88(3):637–54. doi:10.1016/j.critrevonc.2013.07.004.
   PubMed Web of Science ®Google Scholar
• Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986;261(26):12022–7. doi:10.1016/S0021-9258(18)67196-0.
   PubMed Web of Science ®Google Scholar
• Schwalbe R, Dahlbäck B, Hillarp A, Nelsestuen G. Assembly of protein S and C4b-binding protein on membranes. J Biol Chem. 1990;265(27):16074–81. doi:10.1016/S0021-9258(17)46190-4.
   Web of Science ®Google Scholar
• Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys. 1987;252(1):322–8. doi:10.1016/0003-9861(87)90037-3.
   Web of Science ®Google Scholar
• Heeb MJ. et al. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA. 1994;91(7):2728–32. doi:10.1073/pnas.91.7.2728.
   Web of Science ®Google Scholar
• Dahlback B. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders. Int J Lab Hematol. 2016;38(Suppl 1):4–11. doi:10.1111/ijlh.12508.
   PubMedGoogle Scholar
• Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem. 1981;256(21):11128–31. doi:10.1016/S0021-9258(19)68566-2.
   Web of Science ®Google Scholar
• Bos MH, Camire RM. A bipartite autoinhibitory region within the B-domain suppresses function in factor V. J Biol Chem. 2012;287(31):26342–51. doi:10.1074/jbc.M112.377168.
   Web of Science ®Google Scholar
• Norstrom EA, Tran S, Steen M, Dahlbäck B. Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va. J Biol Chem. 2006;281(42):31486–94. doi:10.1074/jbc.M606441200.
   Web of Science ®Google Scholar
• Maurissen LF, Thomassen MCLGD, Nicolaes GAF, Dahlbäck B, Tans G, Rosing J, Hackeng TM. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 2008;111(6):3034–41. doi:10.1182/blood-2007-06-089987.
   Web of Science ®Google Scholar
• Gierula M, Ahnstrom J. Anticoagulant protein S-New insights on interactions and functions. J Thromb Haemost. 2020;18(11):2801–11. doi:10.1111/jth.15025.
   Web of Science ®Google Scholar
• Yegneswaran S, Smirnov MD, Safa O, Esmon NL, Esmon CT, Johnson AE. Relocating the active site of activated protein C eliminates the need for its protein S cofactor. A fluorescence resonance energy transfer study. J Biol Chem. 1999;274(9):5462–8. doi:10.1074/jbc.274.9.5462.
   Web of Science ®Google Scholar
• Smirnov MD, Safa O, Regan L, Mather T, Stearns-Kurosawa DJ, Kurosawa S, Rezaie AR, Esmon NL, Esmon CT. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem. 1998;273(15):9031–40. doi:10.1074/jbc.273.15.9031.
   Web of Science ®Google Scholar
• Gierula M, Salles‐Crawley II, Santamaria S, Teraz‐Orosz A, Crawley JTB, Lane DA, Ahnström J. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex. J Thromb Haemost. 2019;17(12):2056–68. doi:10.1111/jth.14594.
   Web of Science ®Google Scholar
• Gale AJ, Cramer TJ, Rozenshteyn D, Cruz JR. Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V. J Biol Chem. 2008;283(24):16355–62. doi:10.1074/jbc.M708985200.
   Web of Science ®Google Scholar
• Nyberg P, Dahlback B, Garcia de Frutos P. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. FEBS Lett. 1998;433(1–2):28–32. doi:10.1016/S0014-5793(98)00877-1.
   Web of Science ®Google Scholar
• Broze GJ Jr., Girard TJ. Tissue factor pathway inhibitor: structure-function. Front Biosci. 2012;17(1):262–80. doi:10.2741/3926.
   Web of Science ®Google Scholar
• Bajaj MS, Birktoft J, Steer S, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost. 2001;86(4):959–72. doi:10.1055/s-0037-1616518.
   PubMed Web of Science ®Google Scholar
• Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol. 2006;208(3):327–39. doi:10.1002/path.1871.
   PubMed Web of Science ®Google Scholar
• Mast AE. Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein. Arterioscler Thromb Vasc Biol. 2016;36(1):9–14. doi:10.1161/ATVBAHA.115.305996.
   PubMed Web of Science ®Google Scholar
• Tchaikovski SN, Thomassen MC, Costa S-D, Peeters L, Rosing J. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia. Thromb Haemost. 2011;106(11):914–21. doi:10.1160/TH11-04-0244.
   Google Scholar
• Wood JP, Ellery PER, Maroney SA, Mast AE. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface–associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol. 2014;34(1):169–76. doi:10.1161/ATVBAHA.113.302655.
   Web of Science ®Google Scholar
• Castoldi E, Simioni P, Tormen ED, Rosin GJ, Hackeng TM. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. J Thromb Haemost. 2010;8(2):294–300. doi:10.1111/j.1538-7836.2009.03712.x.
   PubMed Web of Science ®Google Scholar
• Reglinska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JTB, Lane DA, Ahnström J. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood. 2014;123(25):3979–87. doi:10.1182/blood-2014-01-551812.
   Web of Science ®Google Scholar
• Taran LD. Factor IX of the blood coagulation system: a review. Biochemistry (Mosc). 1997;62:685–93.
   Web of Science ®Google Scholar
• Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515–23. doi:10.4103/0019-5049.144643.
   PubMedGoogle Scholar
• Chattopadhyay R, Sengupta T, Majumder R. Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C. Arterioscler Thromb Vasc Biol. 2012;32(10):2387–93. doi:10.1161/ATVBAHA.112.250928.
   PubMed Web of Science ®Google Scholar
• Plautz WE, Chattopadhyay R, Goldfeld EI, Samelson-Jones BJ, Pilli VS, Campello E, Datta A, Arruda VR, Simioni P, Majumder R. Padua FIXa resistance to protein S and a potential therapy for hyperactive FIXa. Thromb Res. 2018;170:133–41. doi:10.1016/j.thromres.2018.08.018.
   Web of Science ®Google Scholar
• Plautz WE, Sekhar Pilli VS, Cooley BC, Chattopadhyay R, Westmark PR, Getz T, Paul D, Bergmeier W, Sheehan JP, Majumder R. Anticoagulant protein S targets the factor IXa heparin-binding exosite to prevent thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):816–28. doi:10.1161/ATVBAHA.117.310588.
   Web of Science ®Google Scholar
• Pilli VS, Plautz W, Majumder R. The journey of protein S from an anticoagulant to a signaling molecule. JSM Biochem Mol Biol. 2016;3(1):187–31.
   Google Scholar
• Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry. 1990;29(34):7845–52. doi:10.1021/bi00486a010.
   Web of Science ®Google Scholar
• Watkins PC, Eddy R, Fukushima Y, Byers MG, Cohen EH, Dackowski WR, Wydro RM, Shows TB. The gene for protein S maps near the centromere of human chromosome 3. Blood. 1988;71(1):238–41. doi:10.1182/blood.V71.1.238.238.
   Web of Science ®Google Scholar
• Sankpal UT, Goodison S, Abdelrahim M, Basha R. Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem. 2011;7(5):518–25. doi:10.2174/157340611796799203.
   Web of Science ®Google Scholar
• Hughes Q, Watson M, Cole V, Sayer M, Baker R, Staton J. Upregulation of protein S by progestins. J Thromb Haemost. 2007;5(11):2243–9. doi:10.1111/j.1538-7836.2007.02730.x.
   Web of Science ®Google Scholar
• Dahlback B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol. 2005;25(7):1311–20. doi:10.1161/01.ATV.0000168421.13467.82.
   PubMed Web of Science ®Google Scholar
• Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol. 2008;15(5):529–36. doi:10.1097/MOH.0b013e328309ec97.
   Web of Science ®Google Scholar
• Zhang K, Kurachi S, Kurachi K. Genetic mechanisms of age regulation of protein C and blood coagulation. J Biol Chem. 2002;277(6):4532–40. doi:10.1074/jbc.M109524200.
   Web of Science ®Google Scholar
• Tassin M, Llarena P, Laffaye F, Kaltenbach G. Protein C deficiency in patient with sepsis-associated disseminated intravascular coagulation and deep vein thrombosis. Arch Argent Pediatr. 2013;111(1):e28–30. doi:10.5546/aap.2013.e28.
   Web of Science ®Google Scholar
• Calzavarini S, Prince-Eladnani R, Saller F, Bologna L, Burnier L, Brisset AC, Quarroz C, Reina Caro MD, Ermolayev V, Matsumura Y, et al. Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus. Blood. 2020;135(22):1969–82. doi:10.1182/blood.2019003630.
   Web of Science ®Google Scholar
• Prince R, Bologna L, Manetti M, Melchiorre D, Rosa I, Dewarrat N, Suardi S, Amini P, Fernández JA, Burnier L, et al. Targeting anticoagulant protein S to improve hemostasis in hemophilia. Blood. 2018;131(12):1360–71. doi:10.1182/blood-2017-09-800326.
   PubMed Web of Science ®Google Scholar
• Chowdary P. Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia. Int J Hematol. 2020;111(1):42–50. doi:10.1007/s12185-018-2548-6.
   PubMed Web of Science ®Google Scholar
• Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjnkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, et al. Inherited thrombophilia: part 1. Thromb Haemost. 1996;76(5):651–62. doi:10.1055/s-0038-1650638.
   Web of Science ®Google Scholar
• Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med. 2000;51(1):169–85. doi:10.1146/annurev.med.51.1.169.
   Google Scholar
• Pung-Amritt P, Poort S, Vos H, Bertina R, Mahasandana C, Tanphaichitr V, Veerakul G, Kankirawatana S, Suvatte V. Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency. Thromb Haemost. 1999;81(2):189–92. doi:10.1055/s-0037-1614440.
   Web of Science ®Google Scholar
• Mahasandana C, Suvatte V, Marlar R, Manco-Johnson M, Jacobson L, Hathaway W. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet. 1990;335(8680):61–2. doi:10.1016/0140-6736(90)90201-F.
   Web of Science ®Google Scholar
• Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167–73. doi:10.1016/S0140-6736(98)10266-0.
   PubMed Web of Science ®Google Scholar
• Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Reitsma PH, et al. Protein S deficiency: a database of mutations–summary of the first update. Thromb Haemost. 2000;84(5):918. doi:10.1055/s-0037-1614137.
   Web of Science ®Google Scholar
• Espinosa-Parrilla Y, Morell M, Borrell M, Souto JC, Fontcuberta J, Estivill X, Sala N. Optimization of a simple and rapid single-strand conformation analysis for detection of mutations in the PROS1 gene: identification of seven novel mutations and three novel, apparently neutral, variants. Hum Mutat. 2000;15(5):463–73. doi:10.1002/(SICI)1098-1004(200005)15:5<463:AID-HUMU8>3.0.CO;2-E.
   Web of Science ®Google Scholar
• Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French INSERM network on molecular abnormalities responsible for protein C and protein S deficiencies. Blood. 1995;86(7):2598–605. doi:10.1182/blood.V86.7.2598.2598.
   Web of Science ®Google Scholar
• Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost. 2007;98(3):543–56. doi:10.1160/TH07-03-0199.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83(3):683–90. doi:10.1182/blood.V83.3.683.683.
   Web of Science ®Google Scholar
• Yamazaki T, Sugiura I, Matsushita T, Kojima T, Kagami K, Takamatsu J, Saito H. A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an a to G base exchange in the gene. Thromb Res. 1993;70(5):395–403. doi:10.1016/0049-3848(93)90081-X.
   Web of Science ®Google Scholar
• Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Nishigami K, Chiku M, et al. Protein S–K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107(4):1737–8. doi:10.1182/blood-2005-09-3892.
   Web of Science ®Google Scholar
• Miyata T, Okada H. Abnormality in blood coagulation because of protein S-K196E mutation. Brain Nerves. 2008;60:1285–93.
   Google Scholar
• Kemkes-Matthes B. Acquired protein S deficiency. Clin Investig. 1992;70(6):529–34. doi:10.1007/BF00210237.
   Google Scholar
• Ichinose M, Sasagawa N, Chiba T, Toyama K, Kayamori Y, Kang D. Protein C and protein S deficiencies may be related to survival among hemodialysis patients. BMC Nephrol. 2019;20(1):191. doi:10.1186/s12882-019-1344-8.
   Google Scholar
• van Ommen CH, Fijnvandraat K, Vulsma T, Delemarre-van de Waal HA, Peters M. Acquired protein S deficiency caused by estrogen treatment of tall stature. J Pediatr. 1999;135(4):477–81. doi:10.1016/S0022-3476(99)70171-X.
   Web of Science ®Google Scholar
• Lalan DM, Jassawalla MJ, Bhalerao SA. Successful pregnancy outcome in a case of protein s deficiency. J Obstet Gynaecol India. 2012;62(Suppl 1):21–2. doi:10.1007/s13224-013-0363-9.
   Google Scholar
• Cui C, Yang S, Zhang J, Wang G, Huang S, Li A, Zhang Y, Qiao R. Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy. Thromb Res. 2017;156:82–6. doi:10.1016/j.thromres.2017.05.021.
   PubMed Web of Science ®Google Scholar
• Francis RB Jr. Protein S deficiency in sickle cell anemia. J Lab Clin Med. 1988;111:571–6.
   Web of Science ®Google Scholar
• Pilli VS, Datta A, Afreen S, Catalano D, Szabo G, Majumder R. Hypoxia downregulates protein S expression. Blood. 2018;132(4):452–5. doi:10.1182/blood-2018-04-841585.
   PubMed Web of Science ®Google Scholar
• D’Angelo A, Valle PD, Crippa L, Pattarini E, Grimaldi L, D’Angelo SV. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med. 1993;328(24):1753–7. doi:10.1056/NEJM199306173282405.
   Web of Science ®Google Scholar
• Morange PE, Alessi MC, Barthet MC, Aillaud MF, Harlé JR, Piquet P, Juhan-Vague I. Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosus. Thromb Haemost. 1997;78(5):1416–17. doi:10.1055/s-0038-1665422.
   Web of Science ®Google Scholar
• Lipe B, Ornstein DL. Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin. Circulation. 2011;124(14):e365–8. doi:10.1161/CIRCULATIONAHA.111.044412.
   PubMed Web of Science ®Google Scholar
• Wigle P, Hein B, Bernheisel CR. Anticoagulation: updated guidelines for outpatient management. Am Fam Physician. 2019;100:426–34.
   Web of Science ®Google Scholar
• Campello E, Spiezia L, Simion C, Tormene D, Camporese G, Dalla Valle F, Poretto A, Bulato C, Gavasso S, Radu CM, et al. Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study. J Am Heart Assoc. 2020;9(23):e018917. doi:10.1161/JAHA.120.018917.
   Web of Science ®Google Scholar
• Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood. 2004;103(4):1192–201. doi:10.1182/blood-2003-05-1551.
   Web of Science ®Google Scholar
• Brunet D, Barthet MC, Morange PE, Alessi MC, Borgel D, Gandrille S, Aillaud MF, Juhan-Vague I. Protein S deficiency: different biological phenotypes according to the assays used. Thromb Haemost. 1998;79:446–7.
   Web of Science ®Google Scholar
• Serra J, Sales M, Chitolie A, Domènech P, Rossi E, Borrell M, Dahlbäck B. Multicentre evaluation of IL test™ free PS: a fully automated assay to quantify free protein S. Thromb Haemost. 2002;88(6):975–83. doi:10.1055/s-0037-1613343.
   Web of Science ®Google Scholar
• Persson KE, Hillarp A, Dahlback B. Analytical considerations for free protein S assays in protein S deficiency. Thromb Haemost. 2001;86(5):1144–7. doi:10.1055/s-0037-1616042.
   Web of Science ®Google Scholar
• Hackeng TM, Fernández JA, Dawson PE, Kent SB, Griffin JH. Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S. Proc Natl Acad Sci USA. 2000;97(26):14074–8. doi:10.1073/pnas.260239797.
   Web of Science ®Google Scholar
• Tripodi A, Asti D, Chantarangkul V, Biguzzi E, Mannucci PM. Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay. Blood Coagul Fibrinolysis. 2007;18(6):543–6. doi:10.1097/MBC.0b013e328201ca8a.
   Web of Science ®Google Scholar
• Alshaikh NA, Rosing J, Thomassen MCLGD, Castoldi E, Simioni P, Hackeng TM. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma. J Thromb Haemost. 2017;15(5):950–60. doi:10.1111/jth.13657.
   Web of Science ®Google Scholar
• Neupane S, Pudasaini P, Dhakal B, Awal S, Thapa S, Subedi B. Protein S deficiency with recurrent deep vein thrombosis and post thrombotic syndrome: a case report. JNMA J Nepal Med Assoc. 2022;60(254):892–4. doi:10.31729/jnma.7694.
   Web of Science ®Google Scholar
• Andersen BD, Bisgaard ML, Lind B, Philips M, Villoutreix B, Thorsen S. Characterization and structural impact of five novel PROS1 mutations in eleven protein S-deficient families. Thromb Haemost. 2001;86(6):1392–9. doi:10.1055/s-0037-1616741.
   Web of Science ®Google Scholar
• Klostermeier UC, Limperger V, Kenet G, Kurnik K, Gelas MA, Finckh U, Junker R, Heller C, Zieger B, Knöfler R, et al. Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study. Thromb Haemost. 2015;113(2):426–33. doi:10.1160/TH14-06-0533.
   Web of Science ®Google Scholar
• Gupta A, Ahmed RP, Bhattacharyya M, Kannan M, Biswas A, Kalra V, Saxena R. Protein S deficiency. In: StatPearls. FL: Treasure Island; 2019. p. 233–37.
   Google Scholar
• Lou J, Yin L, Ke X, Zhang L, Xu F, Liu Z. A case-report of two patients with hereditary protein S deficiency treated by rivaroxaban. Blood Coagul Fibrinolysis. 2020;31(6):405–9. doi:10.1097/MBC.0000000000000929.
   Web of Science ®Google Scholar
• Folkeringa N, Brouwer JLP, Korteweg FJ, Veeger NJGM, Erwich JJHM, Holm JP, Van Der Meer J. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007;136(4):656–61. doi:10.1111/j.1365-2141.2006.06480.x.
   Web of Science ®Google Scholar
• Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M. Inhibition of tissue factor: factor VIIa–catalyzed factor IX and factor X activation by TFPI and TFPI constructs. J Thromb Haemost. 2014;12(11):1826–37. doi:10.1111/jth.12713.
   Web of Science ®Google Scholar